对儿科瘤学患者的药物基因组学知识,态度和实践进行系统审查
Claire Moore1,2, Smaro Lazarakis3, Tayla Stenta1
1Pharmacogenomics Team, Murdoch Children's Research Institute, Parkville, Victoria, Australia.
Pharmacology research & perspectives
|November 28, 2023
概括
药物基因组学在儿科瘤学中的实施面临成本和培训差距等障碍. 教育是关键的推动因素,但缺乏具体的计划,需要进一步研究以推进儿科药物基因组学.
科学领域:
- 药物基因组学 药物基因组学
- 儿科瘤学 儿科瘤学
- 临床实施 临床实施
背景情况:
- 尽管存在指导方针,但药物基因组学在临床实践中未得到充分利用.
- 实施的挑战仍然存在,特别是在儿科瘤学中.
- 了解推动者和障碍者对于更广泛的采用至关重要.
研究的目的:
- 系统地审查在儿科瘤学中实施药物基因组学的推动者和障碍.
- 评估医疗保健专业人员和消费者的知识,态度和做法.
- 确定影响药物基因组学在儿科癌症护理中的整合因素.
主要方法:
- 对Medline,Embase,Emcare和PsycINFO数据库进行系统审查.
- 纳入标准集中在评估药物基因组学在儿科瘤学中的实施研究上.
- 对已识别的研究进行分析,以合成促进因素和障碍因素.
主要成果:
- 只有三项研究符合纳入标准.
- 消费者的担忧包括成本,保险歧视,数据共享和隐私.
- 医疗保健专业人员表现出积极的态度,但缺乏经验和培训;教育是关键的推动因素.
- 在儿科瘤学中缺乏报告的药物基因组教育计划.
结论:
- 教育是药物基因组学在儿科瘤学中的实施的关键推动因素.
- 解决消费者担忧和医疗保健专业人员培训需求至关重要.
- 需要进一步的研究来确定实施决定因素,并推进儿科药物基因组学.
相关概念视频
Analysis of Population Pharmacokinetic Data
266
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
266
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Nonlinear Pharmacokinetics: Overview
390
Nonlinear or dose-dependent pharmacokinetics is a phenomenon that occurs when the pharmacokinetic parameters of certain drugs deviate from linear pharmacokinetics at higher doses. These drugs do not follow the expected first-order kinetics, where the rate of drug elimination is directly proportional to the drug concentration. Instead, they exhibit a nonlinear relationship, which can be attributed to several factors.
Nonlinearity can arise due to the saturation of plasma protein-binding or...
Nonlinearity can arise due to the saturation of plasma protein-binding or...
390
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
Nonlinear Pharmacokinetics: Role of Transporters
53
A drug's nonlinear kinetics can be influenced by a diverse range of transporter proteins that serve as crucial players in drug distribution. These transporters, found within cells, can enhance or reduce local drug concentrations by facilitating the influx or efflux of drugs. For instance, the expression of xenobiotic transporters can be influenced by factors such as age and gender, potentially impacting the linearity of drug response.
Polymorphisms occurring in drug transporters can alter...
Polymorphisms occurring in drug transporters can alter...
53
Factors Affecting Drug Response: Overview
2.0K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
2.0K


